研究了普洱茶调控非酒精性脂肪肝大鼠肠道对长链脂肪酸的吸收,并探讨了其可能机制。将36只SD大鼠随机分成正常对照组、脂肪肝模型组和普洱茶干预组,每组12只。实验第8周末处死所有大鼠,测定大鼠体质量、肝指数及血清血脂水平;采用定量PCR测定大鼠肠道黏膜脂质吸收相关蛋白细胞分化抗原36（Cluster of differentiation 36,CD36）、紧密连接相关蛋白如闭锁蛋白（Occludin）、紧密连接蛋白（Zonula occludens 1,ZO-1）和肿瘤坏死因子α（Tumor necrosis factor-α, TNF-α）基因表达水平。研究结果表明,与模型组相比,普洱茶组大鼠体质量和血清LDL-C水平分别下降了16.12%和42.59%;此外,普洱茶组大鼠小肠组织CD36、TNF-α表达水平明显降低,而Occludin、ZO-1表达水平明显升高。研究发现,普洱茶对NAFLD大鼠肠道长链脂肪酸吸收及肠道紧密连接蛋白有一定程度的调控作用,尤其是对NAFLD早期发生发展中游离脂肪酸过度沉积的“第一次打击”有防治价值。
In this study, the influence of Pu-erh tea on the absorption of long chain fatty acids in non-alcoholic fatty liver disease (NAFLD) rats was analyzed. Moreover, the possible interventional mechanism was also discussed. Thirty-six SD rats were randomly divided into three groups, normal group (NG), NAFLD group, and Pu-erh tea group (PTG), 12 rats for each group. All rats were killed after 8 weeks. Rat weight, liver index, serum lipid level, intestinal lipid absorption protein (CD36), tight junction proteins (Occludin, ZO-1), and TNF-α mRNA were measured.
[1] Wieland AC, Mettler P, McDermott MT, et al. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk[J]. J Clin Gastroenterol, 2015, 49(1): e6-e10.
[2] Ogawa Y, Imajo K, Yoneda M, et al.Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides[J]. Nihon Rinsho, 2013, 71(9): 1623-1629.
[3] Glatz JF, Luiken JJ, Bonen A.Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease[J]. Physiol Rev, 2010, 90(1): 367-417.
[4] Miele L, Valenza V, La Torre G, et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J]. Hepatology, 2009, 49(6): 1877-1887.
[5] Park EJ, Thomson AB, Clandinin MT.Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation[J]. J Pediatr Gastroenterol Nutr, 2010, 50(3): 321-328.
[6] Reid AE.Nonalcoholic steatohepatitis[J]. Gastroenterology, 2001, 121(3): 710-723.
[7] 陈宗懋, 甄永苏. 茶叶的保健功能 [M]. 北京: 科学出版社, 2014.
[8] Dulloo AG, Duret C, Rohrer D, et al.Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans[J]. Am J Clin Nutr, 1999, 70(6): 1040-1045.
[9] Chen ZM, Lin Z.Tea and human health: biomedical functions of tea active components and current issues[J]. J Zhejiang Univ Sci B, 2015, 16(2): 87-102.
[10] Cao ZH, Gu DH, Lin QY, et al.Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity[J]. Phytother Res, 2011, 25(2): 234-238.
[11] Hou Y, Shao W, Xiao R, et al.Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model[J]. Exp Gerontol, 2009, 44(6/7): 434-439.
[12] Lee LK, Foo K Y.Recent advances on the beneficial use and health implications of Pu-Erh tea[J]. Food Research International, 2013, 53: 619-628.
[13] Kuo KL, Weng MS, Chiang CT, et al.Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats[J]. J Agric Food Chem, 2005, 53(2): 480-489.
[14] 肖凯, 朱晟易, 童钰铃. 普洱茶水提取物对大鼠非酒精性脂肪性肝病的干预作用[J]. 第三军医大学学报, 2013: 35(18): 1992-1995.
[15] Han X, Fink MP, Yang R, et al.Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice[J]. Shock, 2004, 21(3): 261-270.
[16] Harhaj NS, Antonetti DA.Regulation of tight junctions and loss of barrier function in pathophysiology[J]. Int J Biochem Cell Biol, 2004, 36(7): 1206-1237.
[17] 许腊梅,孙丹莉,张予蜀. 紧密连接蛋白Occludin在非酒精性脂肪肝大鼠肠上皮细胞中的表达及其与TNF-α的关系[J]. 世界华人消化杂志, 2010, 18(10): 981-986.
[18] Fanning AS, Jameson BJ, Jesaitis LA, et al.The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton[J]. J Biol Chem, 1998, 273(45): 29745-29753.
[19] Liang Y, Zhang L.A study on chemical estimation of pu-erh tea quality[J]. Journal of the science of food agriculture, 2005, 95: 286-292.
[20] Zhou ZH, Zhang YJ, Xu M, et al.Puerins A and B, two new 8-C substituted flavan-3-ols from Pu-er tea[J]. J Agric Food Chem, 2005, 53(22): 8614-8617.
[21] Yang DJ, Hwang LS.Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea[J]. J Chromatogr A, 2006, 1119(1/2): 277-284.
[22] 吕海鹏, 林智, 谷记平, 等. 普洱茶中的没食子酸研究[J]. 茶叶科学, 2007, 27(2): 104-110.
[23] Lv H, Zhu Y, Tan J, et al.Bioactive compounds from Pu-erh tea with therapy for hyperlipidaemia[J]. Journal of Functional Foods, 2015, 19: 194-203.
[24] 吕海鹏, 谷记平, 林智, 等. 普洱茶的化学成分及生物活性研究进展[J]. 茶叶科学, 2007, 27(1): 8-18.
[25] 东方, 杨子银, 何普明, 等. 普洱茶抗氧化活性成分的LC-MS分析[J]. 中国食品学报, 2008, 8(2):133-141.
浙公网安备 33019902000101号 
